SCHEMBL7975208

SCHEMBL7975208

Cc1ccc(C)c(C#N)c1C#N

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.46
CYP2C19 P33261 1/20 0.46
ALDH1A1 P00352 7/20 0.44
KDM4E B2RXH2 7/20 0.44
HPGD P15428 3/20 0.44
MAPT P10636 2/20 0.44
ALOX15 P16050 1/20 0.44
HSD17B10 Q99714 1/20 0.44
APOBEC3G Q9HC16 1/20 0.44
TSHR P16473 1/20 0.43
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
CYP2A6 P11509 1/20 0.41
HAVCR2 Q8TDQ0 1/20 0.39
RECQL P46063 2/20 0.37
UPP1 Q16831 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
GAA P10253 3/20 0.36
CACNA1B Q00975 1/20 0.36
APBA1 Q02410 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31050110 1.00 CYP1A2 (0.46) CYP1A2CYP2C19ALDH1A1KDM4EHPGD
SCHEMBL17570552 0.87 TSHR (0.46) CYP1A2CYP2C19ALDH1A1KDM4EHPGD
SCHEMBL5684102 0.85 CYP1A2 (0.42) CYP1A2CYP2C19ALDH1A1KDM4EHPGD
SCHEMBL19914848 0.85 CYP1A2 (0.42) CYP1A2CYP2C19ALDH1A1KDM4EHPGD
SCHEMBL28227844 0.84 CYP1A2 (0.38) CYP1A2CYP2C19ALDH1A1KDM4EHPGD
SCHEMBL102473 0.81 CYP1A2 (0.59) CYP1A2CYP2C19ALDH1A1KDM4EHPGD
SCHEMBL8872487 0.81 POLB (0.42) CYP1A2CYP2C19ALDH1A1KDM4EHPGD
SCHEMBL14051608 0.81 CYP1A2 (0.39) CYP1A2CYP2C19ALDH1A1KDM4EHPGD
SCHEMBL28349620 0.79 CYP1A2 (0.57) CYP1A2CYP2C19ALDH1A1KDM4EHPGD
Ethane SCHEMBL2154002 0.79 CYP1A2 (0.57) CYP1A2CYP2C19ALDH1A1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11359140-B2 Liquid crystal composition and liquid crystal display device JIANGSU HECHENG DISPLAY TECHNOLOGY CO., LTD. (CN) 2022-06-14 US disclosed
WO-2021127952-A1 LOW-VISCOSITY, FAST-RESPONSE LIQUID CRYSTAL COMPOSITION AND APPLICATION IN LIQUID CRYSTAL DISPLAY 北京八亿时空液晶科技股份有限公司 2021-07-01 WO disclosed
EP-3623451-B1 COMPOUND MERCK PATENT GMBH (DE) 2021-01-20 EP disclosed
US-20200385635-A1 LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JIANGSU HECHENG DISPLAY TECHNOLOGY CO., LTD. (CN) 2020-12-10 US disclosed
US-10626666-B2 Device for regulating the passage of light MERCK PATENT GMBH (DE) 2020-04-21 US disclosed
EP-3623451-A1 COMPOUND Merck Patent GmbH (DE) 2020-03-18 EP disclosed
EP-3083885-B1 WINDOW MERCK PATENT GMBH (DE) 2019-10-09 EP disclosed
WO-2019184860-A1 LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE 江苏和成显示科技有限公司 2019-10-03 WO disclosed
US-9995967-B2 Liquid crystal display device SHARP KABUSHIKI KAISHA (JP) 2018-06-12 US disclosed
US-20170256720-A1 ORGANIC LIGHT-EMITTING DEVICE, AND LIGHT-EMITTING MATERIAL AND COMPOUND USED THEREFOR KYULUX, INC. (JP) 2017-09-07 US disclosed
US-7291213-B2 Ink composition and inkjet recording method FUJIFILM CORPORATION (JP) 2007-11-06 US disclosed
US-20070172608-A1 Inkjet-recording medium, production method thereof, inkjet-recording method, inkjet-recording set, and inkjet-recording object FUJIFILM CORPORATION (JP) 2007-07-26 US disclosed
US-20070171267-A1 Inkjet-recording method and injet-recording material FUJIFILM CORPORATION (JP) 2007-07-26 US disclosed
US-7244730-B2 2-iminopyrrolidine derivatives EISAI CO., LTD (JP) 2007-07-17 US disclosed
US-7220302-B2 Ink and ink set for inkjet, and inkjet recording method FUJIFILM CORPORATION (JP) 2007-05-22 US disclosed
US-20070052783-A1 Ink for inkjet printing ink set for inkjet printing inkjet recording material and producing method for inkjet recording material and inkjet recording method FUJIFILM CORPORATION (JP) 2007-03-08 US disclosed
US-6307147-B1 PHTHALOCYANINE DYES; POLYMORPHISM RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY 2001-10-23 US disclosed
EP-0998481-A1 PHOTOSENSITIZERS JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) 2000-05-10 EP disclosed
US-6051702-A PHTHALOCYANINE COMPOUNDS USED AS DYES FOR APPLICATIONS AS SOLAR ORGANIC PHOTOVOLTAIC) MATERIALS AND AS ELECTROPHOTOGRAPHIC (XEROGRAPHIC) ORGANIC PHOTOCONDUCTOR MATERAIALS RUTGERS, THE UNIVERSITY OF NEW JERSEY (US) 2000-04-18 US disclosed
WO-1999003868-A1 PHOTOSENSITIZERS JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) 1999-01-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170256720-A1 ORGANIC LIGHT-EMITTING DEVICE, AND LIGHT-EMITTING MATERIAL AND COMPOUND USED THEREFOR CRY1, WEE1, OR51E2 CYP1A2 347/4885CYP2C19 133/4885ALDH1A1 80/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.